Please login to the form below

Not currently logged in
Email:
Password:

lung cancer

This page shows the latest lung cancer news and features for those working in and with pharma, biotech and healthcare.

Pivotal data sets up Tecentriq filing in small cell lung cancer

Pivotal data sets up Tecentriq filing in small cell lung cancer

Roche’s PD-L1 inhibitor Tecentriq has become the first cancer immunotherapy to improve survival in extensive-stage small cell lung cancer (ES-SCLC), putting it on course to end a ... Small cell lung cancer is less common that the non-small cell lung

Latest news

More from news
Approximately 99 fully matching, plus 691 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    use in lung cancer patients. ... She played a key role in the development and approval of Tagrisso, AstraZeneca’s next-generation EGFR-targeting lung cancer treatment that is proving a major advance on existing reatments, and

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    We are now on the crest of a new wave in cancer care. ... But to do this, communication is crucial. A shining example is MoovCare, a web-based application through which patients report their own symptoms of lung cancer to enable earlier detection of

  • Let’s change the conversation about cancer Let’s change the conversation about cancer

    Cancer identity is changing. Cancer has typically been defined and diagnosed by the place it originates in the body, eg lung cancer. ... As Lorraine Dallas, Director of Information and Support at the Roy Castle Lung Cancer Foundation, pointed out,

  • The good, the bad and the ugly The good, the bad and the ugly

    One commentator has remarked that while some companies’pipelines are in terrible shape, in certain therapy areas - notably cancer - innovation is so rich it could become a problem. ... Merck’s success in oncology will likely continue, driven by

  • The tipping point The tipping point

    In 2016 alone, there were approximately 30 oncology drugs in late stage development for breast cancer, leukaemia, lung cancer and ovarian cancer.

More from intelligence
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest appointments

  • Astellas bolsters oncology clinical development leadership Astellas bolsters oncology clinical development leadership

    breast cancer, leukaemia, lung cancer and prostate cancer. ... of Medicine and the University of Texas MD Anderson Cancer Center.

  • Iris Pauporté joins OSE Immunotherapeutics Iris Pauporté joins OSE Immunotherapeutics

    Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research

  • Astellas promotes John Demaree Astellas promotes John Demaree

    Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib). ... Mark Reisenauer, senior vice

  • Merck appoints ex-Pfizer exec as global head of oncology Merck appoints ex-Pfizer exec as global head of oncology

    lung cancer therapy, which is expected in 2017. ... bring new therapeutic options to patients living with cancer. “

  • Merck appoints new senior vice president Merck appoints new senior vice president

    Radvanyi will focus on leading the discovery of oncology therapies that leverage the natural ability of the body's immune system to fight cancer, as well as identifying biomarkers with the ... indications including lung, cervical and breast cancer.

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics